InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Perry Andrew, Directeur Commercial. Insider active across 1 companies, notably G1 Therapeutics, Inc.. Aggregated, 2 filings have been logged. The latest transaction was disclosed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
06,000 shares0
Common Stock
SEC:0001562180-22-000308·
06,000 shares0
Common Stock
SEC:0001562180-22-000308:0·
2 of 2 declarations
About Perry Andrew
Perry Andrew is the Chief Commercial Officer at G1 Therapeutics, Inc. In this role, he is responsible for the company's commercial strategy and sales. His expertise in business development is essential for the growth of G1 Therapeutics, Inc.
